top of page

The Digital Health Mass Extinction of 2026 Has Already Started.

  • Nov 17, 2025
  • 2 min read

Over the last 60 days, something seismic has happened inside payer organizations — and almost no one in digital health is prepared for it.


Multiple national + regional plans quietly updated internal guidance with a brutal new rule:


“If a program doesn’t bend total medical cost within 12 months, it moves to non-renewal.”


Not “promising outcomes.”

Not “validated evidence.”

Not “strong engagement.”


Total cost curve reduction — fast — or you disappear.


This is the downstream math of:

  • 2024–25 medical cost overruns landing 7–11% above forecast

  • MA actuaries modeling zero-margin bid cycles for 2026

  • Risk-adjusted PMPM volatility at the highest level since 2013

  • Employer coalitions rejecting “soft ROI” outright

  • CFOs demanding finance-grade attribution models

  • Quiet freezes across metabolic, behavioral, and RPM-adjacent categories

  • Regional Blues tightening continuity + cost trajectory standards to historic levels


Here’s the truth no founder wants to hear:


Clinical evidence no longer sells. Economic clarity does.


Most digital health companies don’t actually have an economic model.They have a clinical narrative wearing an ROI costume.


And payers can spot it instantly.


Axis Law #1:


If you can’t prove cost-curve impact in 12 months, you don’t have a commercial model — you have a burn rate.


This is the dividing line of 2026.


The companies breaking through the extinction event share one capability:


They translate validated clinical outcomes into payer-grade economic clarity — actuarial-sound attribution, defensible cost curves, and contracting structures that survive CFO review.


This is the commercialization architecture I build with teams every day.


Because here’s the part no one is saying out loud:


2026 is the first year where renewal will be determined by economics, not clinical storytelling — and almost no one is ready for that shift.


If you enter renewal season with a “value prop deck,” you get filtered out.

If you enter with economic clarity, you become uncuttable.


If you need the payer-aligned economic clarity model your team doesn’t yet have, message me — this is exactly what Axis builds first.


—@axisgrowthpartners | axisgrowthpartners.co


Tom, Founder & Commercialization Architect | Axis Growth Partners tomriley@axisgrowthpartners.co | axisgrowthpartners.co

 
 
 

Recent Posts

See All
MA Arbitrage Is Collapsing

CMS Made It Official. Medicare is undergoing a structural shift most healthcare operators and healthtech companies are misreading. This isn’t a policy tweak.It ’s the collapse of the economic arbitrag

 
 
 

Comments


bottom of page